3 results
Approved WMORecruiting
To assess the safety and biodistribution of 89Zr-pembrolizumab and its uptake in tumor and target irAE tissues
Approved WMOWill not start
Primary objective: To evaluate the expected increase of the Microvascular Flow Index perioperative using a SDF-imaging device and the systemic inflammatory response by measuring inflammation biomarkers.Secondary objective: To learn more about theā¦
Approved WMORecruiting
The objective is to determine whether etidronate can halt or attenuate disease progression in patients with Fahr*s disease or syndrome.